Ballentine Partners’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$380K Buy
2,813
+91
+3% +$16K ﹤0.01% 674
2026
Q1
$489K Sell
2,722
-39
-1% -$6.66K 0.01% 541
2025
Q4
$391K Buy
2,761
+35
+1% +$3.97K 0.01% 595
2025
Q3
$221K Buy
+2,726
New +$210K ﹤0.01% 864
2025
Q1
Sell
-2,371
Closed -$204K 916
2024
Q4
$204K Buy
2,371
+3
+0.1% +$299 ﹤0.01% 775
2024
Q3
$224K Buy
+2,368
New +$210K ﹤0.01% 709
2023
Q4
Sell
-1,496
Closed -$254K 686
2023
Q3
$254K Sell
1,496
-98
-6% -$19.5K 0.01% 477
2023
Q2
$356K Sell
1,594
-263
-14% -$53.8K 0.01% 405
2023
Q1
$410K Buy
1,857
+117
+7% +$28.8K 0.01% 340
2022
Q4
$377K Buy
1,740
+422
+32% +$112K 0.01% 329
2022
Q3
$348K Buy
1,318
+84
+7% +$21.4K 0.01% 307
2022
Q2
$258K Buy
1,234
+326
+36% +$72.7K 0.01% 350
2022
Q1
$201K Buy
+908
New +$192K 0.01% 440

Other funds holding ALB

Ballentine Partners's ALB Position: Q2 2026 in Review

Ballentine Partners increased its Albemarle (ALB) stake by 3.3% in Q2 2026, buying an estimated $16K and bringing the position to 2,813 shares worth $380K. The position accounts for ﹤0.01% of the portfolio, ranked #674.

Ballentine Partners first reported a position in ALB in Q1 2022 and has held it in 13 quarters since. The position peaked at $489K in Q1 2026. 151 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • Ballentine Partners held 2,813 shares of Albemarle worth $380K as of Q2 2026.
  • Ballentine Partners bought 91 Albemarle shares in Q2 2026, an estimated $16K.
  • Albemarle made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #674 holding.
  • Ballentine Partners first reported a position in Albemarle in Q1 2022 and has held it in 13 quarters since.
  • Ballentine Partners's Albemarle position peaked at $489K in Q1 2026.
  • 151 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.